deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT06103227

The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth

The Effect of Low Doses of Intermediate Acting Corticosteroids on the Prolongation of Pregnancy in Threatened Preterm Birth

Sponsor: University of Mostar

Conditions Preterm Birth
Interventions Prednisone 5Mg
Updated 4 times since 2023 Last updated: Feb 15, 2025 Started: Nov 8, 2023 Primary completion: Nov 25, 2024 Completion: Dec 2, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Preterm Birth and is currently completed. University of Mostar leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotNot Yet Recruiting~Mar 2025 – present · 16 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Mar 2025 — Present [monthly]

    Completed PHASE2/PHASE3

    Status: Not Yet RecruitingCompleted

  2. Sep 2024 — Mar 2025 [monthly]

    Not Yet Recruiting PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Nov 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Mostar
Data source: University of Mostar

For direct contact, visit the study record on ClinicalTrials.gov .